Skip to main content
Erschienen in: European Journal of Nutrition 6/2011

01.09.2011 | Original Contribution

Dietary deoxynucleic acid induces type 2 T-helper immune response through toll-like receptor 9 in mice

verfasst von: Mariko Nakamoto, Emi Shuto, Toshio Hosaka, Tohru Sakai

Erschienen in: European Journal of Nutrition | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

It has been shown that dietary nucleotides modulate immune response. Due to their unique properties in immune responses, nucleotides are used as immunonutrition in the field of clinical nutrition.

Aim of the study

In this study, we examined the effect of dietary deoxynucleic acid (DNA) on antigen (Ag)-specific immune response in ovalbumin (OVA)-immunized BALB/c mice and determined the mechanism using toll-like receptor 9 (TLR9) knock-out (KO) mice.

Methods

BALB/c or TLR9 KO mice were fed control and 1% DNA diets and immunized with OVA. Spleen cells from OVA-immunized mice were stimulated with OVA in vitro, and the contents of IFN-γ and IL-4 in supernatants were measured by an ex vivo system. CD11c+ dendritic cells were purified, and ability of cytokine induction to CD4+ cells was examined.

Results

The level of OVA-specific IL-4 production in the DNA group was significantly higher than that in the control group. In contrast, the level of OVA-specific IFN-γ production in the DNA group was lower than that in the control group. The DNA diet decreased Ag-specific IL-4 production and enhanced Ag-specific IFN-γ production in TLR9 KO mice. CD11c+ DCs from mice fed the DNA diet had a greater ability than CD11c+ DCs from mice fed the control diet to induce the production of IL-4 from DO11.10 CD4+ T cells.

Conclusions

Dietary DNA increases Ag-specific IL-4 production and decreases IFN-γ production through a TLR9-dependent pathway. CD11c+ dendritic cells are target cells in dietary DNA-induced immune regulation.
Literatur
1.
Zurück zum Zitat Aggett P, Leach JL, Rueda R, MacLean WC Jr (2003) Innovation in infant formula development: a reassessment of ribonucleotides in 2002. Nutrition 19:375–384CrossRef Aggett P, Leach JL, Rueda R, MacLean WC Jr (2003) Innovation in infant formula development: a reassessment of ribonucleotides in 2002. Nutrition 19:375–384CrossRef
2.
Zurück zum Zitat Pickering LK, Granoff DM, Erickson JR, Masor ML, Cordle CT, Schaller JP, Winship TR, Paule CL, Hilty MD (1998) Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 101:242–249CrossRef Pickering LK, Granoff DM, Erickson JR, Masor ML, Cordle CT, Schaller JP, Winship TR, Paule CL, Hilty MD (1998) Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 101:242–249CrossRef
3.
Zurück zum Zitat Schaller JP, Kuchan MJ, Thomas DL, Cordle CT, Winship TR, Buck RH, Baggs GE, Wheeler JG (2004) Effect of dietary ribonucleotides on infant immune status. Part 1: humoral responses. Pediatr Res 56:883–890CrossRef Schaller JP, Kuchan MJ, Thomas DL, Cordle CT, Winship TR, Buck RH, Baggs GE, Wheeler JG (2004) Effect of dietary ribonucleotides on infant immune status. Part 1: humoral responses. Pediatr Res 56:883–890CrossRef
4.
Zurück zum Zitat Buck RH, Thomas DL, Winship TR, Cordle CT, Kuchan MJ, Baggs GE, Schaller JP, Wheeler JG (2004) Effect of dietary ribonucleotides on infant immune status. Part 2: immune cell development. Pediatr Res 56:891–900CrossRef Buck RH, Thomas DL, Winship TR, Cordle CT, Kuchan MJ, Baggs GE, Schaller JP, Wheeler JG (2004) Effect of dietary ribonucleotides on infant immune status. Part 2: immune cell development. Pediatr Res 56:891–900CrossRef
5.
Zurück zum Zitat Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR (1995) Early enteral administration of a formula (impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23:436–449CrossRef Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR (1995) Early enteral administration of a formula (impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23:436–449CrossRef
6.
Zurück zum Zitat Braga M, Gianotti L, Vignali A, Di Carlo V (1998) Immunonutrition in gastric cancer surgical patients. Nutrition 14:864–865CrossRef Braga M, Gianotti L, Vignali A, Di Carlo V (1998) Immunonutrition in gastric cancer surgical patients. Nutrition 14:864–865CrossRef
7.
Zurück zum Zitat Kubo C, Johnson BC, Gajjar A, Good RA (1987) Crucial dietary factors in maximizing life span and longevity in autoimmune-prone mice. J Nutr 117:1129–1135 Kubo C, Johnson BC, Gajjar A, Good RA (1987) Crucial dietary factors in maximizing life span and longevity in autoimmune-prone mice. J Nutr 117:1129–1135
8.
Zurück zum Zitat Carver JD (1994) Dietary nucleotides: cellular immune, intestinal and hepatic system effect. J Nutr 124:S144–S148 Carver JD (1994) Dietary nucleotides: cellular immune, intestinal and hepatic system effect. J Nutr 124:S144–S148
9.
Zurück zum Zitat Yamauchi K, Adjei AA, Ameho CK, Chan YC, Kulkarni AD, Sato S, Okamoto K, Yamamoto S (1996) A nucleoside-nucleotide mixture and its components increase lymphoproliferative and delayed hypersensitivity responses in mice. J Nutr 126:1571–1577 Yamauchi K, Adjei AA, Ameho CK, Chan YC, Kulkarni AD, Sato S, Okamoto K, Yamamoto S (1996) A nucleoside-nucleotide mixture and its components increase lymphoproliferative and delayed hypersensitivity responses in mice. J Nutr 126:1571–1577
10.
Zurück zum Zitat Jyonouchi H, Sun S (1996) An orally supplemented mononucleotide mixture prevents the decrease in T cell-dependent humoral immunity in C57BL/6 mice fed a nucleotide-free diet. J Nutr 126:1586–1593 Jyonouchi H, Sun S (1996) An orally supplemented mononucleotide mixture prevents the decrease in T cell-dependent humoral immunity in C57BL/6 mice fed a nucleotide-free diet. J Nutr 126:1586–1593
11.
Zurück zum Zitat Jyonouchi H, Sun S, Sato S (1996) Nucleotide-free diet suppresses antigen-driven cytokine production by primed T cells: effects of supplemental nucleotides and dietary fatty acids. Nutrition 12:608–615CrossRef Jyonouchi H, Sun S, Sato S (1996) Nucleotide-free diet suppresses antigen-driven cytokine production by primed T cells: effects of supplemental nucleotides and dietary fatty acids. Nutrition 12:608–615CrossRef
12.
Zurück zum Zitat Jyonouchi H, Sun S, Abiru T, Winship T, Kuchan MJ (2000) Dietary nucleotides modulate antigen-specific type 1 and type 2 T-cell responses in young C57BL/6 mice. Nutrition 16:442–446CrossRef Jyonouchi H, Sun S, Abiru T, Winship T, Kuchan MJ (2000) Dietary nucleotides modulate antigen-specific type 1 and type 2 T-cell responses in young C57BL/6 mice. Nutrition 16:442–446CrossRef
13.
Zurück zum Zitat Nagafuchi S, Hachimura S, Totsuka M, Takahashi T, Goto M, Yajima T, Kuwata T, Habu S, Kaminogawa S (2000) Dietary nucleotides can up-regulate antigen-specific Th1 immune responses and suppress antigen-specific IgE responses in mice. Int Arch Allergy Immunol 122:33–341CrossRef Nagafuchi S, Hachimura S, Totsuka M, Takahashi T, Goto M, Yajima T, Kuwata T, Habu S, Kaminogawa S (2000) Dietary nucleotides can up-regulate antigen-specific Th1 immune responses and suppress antigen-specific IgE responses in mice. Int Arch Allergy Immunol 122:33–341CrossRef
14.
Zurück zum Zitat Sudo Naiba Y, Takaki A, Tanaka K, Yu XN, Oyama N, Koga Y, Kubo C (2000) Dietary nucleic acids promote a shift in Th1/Th2 balance toward Th1-dominant immunity. Clin Exp Allergy 30:979–987CrossRef Sudo Naiba Y, Takaki A, Tanaka K, Yu XN, Oyama N, Koga Y, Kubo C (2000) Dietary nucleic acids promote a shift in Th1/Th2 balance toward Th1-dominant immunity. Clin Exp Allergy 30:979–987CrossRef
15.
Zurück zum Zitat Jyonouchi H, Sun S, Winship T, Kuchan MJ (2001) Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice. J Nutr 131:1165–1170 Jyonouchi H, Sun S, Winship T, Kuchan MJ (2001) Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice. J Nutr 131:1165–1170
16.
Zurück zum Zitat Jyonouchi H, Sun S, Winship T, Kuchan MJ (2003) Dietary ribonucleotides increase antigen-specific type 1 T-helper cells in the regional draining lymph nodes in young BALB/cJ mice. Nutrition 19:41–46CrossRef Jyonouchi H, Sun S, Winship T, Kuchan MJ (2003) Dietary ribonucleotides increase antigen-specific type 1 T-helper cells in the regional draining lymph nodes in young BALB/cJ mice. Nutrition 19:41–46CrossRef
17.
Zurück zum Zitat Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (2003) Integration of interferon alpha/beta signaling to p53 responses in tumor suppression and antiviral defense. Nature 424:516–523CrossRef Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (2003) Integration of interferon alpha/beta signaling to p53 responses in tumor suppression and antiviral defense. Nature 424:516–523CrossRef
18.
Zurück zum Zitat Kogiso M, Sakai T, Mitsuya K, Komatsu T, Yamamoto S (2006) Genistein suppresses antigen-specific immune responses through competition with 17β-estradiol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 22:802–809CrossRef Kogiso M, Sakai T, Mitsuya K, Komatsu T, Yamamoto S (2006) Genistein suppresses antigen-specific immune responses through competition with 17β-estradiol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 22:802–809CrossRef
19.
Zurück zum Zitat Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357 Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
20.
Zurück zum Zitat Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173CrossRef Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173CrossRef
21.
Zurück zum Zitat Wagner H (1999) Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol 73:329–368CrossRef Wagner H (1999) Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol 73:329–368CrossRef
22.
Zurück zum Zitat Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM (2004) Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113:212–223CrossRef Vollmer J, Weeratna RD, Jurk M, Samulowitz U, McCluskie MJ, Payette P, Davis HL, Schetter C, Krieg AM (2004) Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113:212–223CrossRef
23.
Zurück zum Zitat McCluskie MJ, Weeratna RD, Davis HL (2001) The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine 19:2657–2660CrossRef McCluskie MJ, Weeratna RD, Davis HL (2001) The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine 19:2657–2660CrossRef
24.
Zurück zum Zitat McCluskie MJ, Davis HL (2000) Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413–422CrossRef McCluskie MJ, Davis HL (2000) Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine 19:413–422CrossRef
25.
Zurück zum Zitat Sano K, Shirota H, Terui T, Hattori T, Tamura G (2003) Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner. J Immunol 170:2367–2373 Sano K, Shirota H, Terui T, Hattori T, Tamura G (2003) Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner. J Immunol 170:2367–2373
26.
Zurück zum Zitat Fedianina LN, Zaitseva EA, Epshtein LM, Besednova NN, Somov GP (2005) Experimental study on impact of salmon milt DNA on T-cellular immunity. Antibiot Khimioter 50:14–17 Fedianina LN, Zaitseva EA, Epshtein LM, Besednova NN, Somov GP (2005) Experimental study on impact of salmon milt DNA on T-cellular immunity. Antibiot Khimioter 50:14–17
27.
Zurück zum Zitat Besednova NN, Kasianenko I, Epshtein LM, Gazha AK (1999) The immunotropic properties of the deoxyribonucleic acid from Salmonidase milt. Antibiot Khimioter 44:13–15 Besednova NN, Kasianenko I, Epshtein LM, Gazha AK (1999) The immunotropic properties of the deoxyribonucleic acid from Salmonidase milt. Antibiot Khimioter 44:13–15
28.
Zurück zum Zitat Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15:921–929CrossRef Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15:921–929CrossRef
29.
Zurück zum Zitat Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939CrossRef Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939CrossRef
30.
Zurück zum Zitat Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15:940–945CrossRef Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15:940–945CrossRef
Metadaten
Titel
Dietary deoxynucleic acid induces type 2 T-helper immune response through toll-like receptor 9 in mice
verfasst von
Mariko Nakamoto
Emi Shuto
Toshio Hosaka
Tohru Sakai
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 6/2011
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-010-0153-4

Weitere Artikel der Ausgabe 6/2011

European Journal of Nutrition 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.